Patents/Assignees

Pharmacosmos Holding A/S

15 patents in portfolio

US12565502utility2026
Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c] [1,2,4]triazin]-3′-ones as Cyclin-dependent Kinase Inhibitors
0 cites
US12534472utility2026
Morphic Forms of Trilaciclib and Methods of Manufacture Thereof
0 cites
US12527798utility2026
Preservation of Immune Response During Chemotherapy Regimens
0 cites
US12497404utility2025
Morphic Forms of Trilaciclib and Methods of Manufacture Thereof
0 cites
US12479855utility2025
Morphic Forms of Trilaciclib and Methods of Manufacture Thereof
0 cites
US12364697utility2025
G1T38 Superior Dosage Regimes
0 cites
US12312360utility2025
Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as Cyclin-dependent Kinase Inhibitors
0 cites
US12303486utility2025
Treating Iron Deficiency with Ferric Carboxymaltose
0 cites
US12295934utility2025
Treating Iron Deficiency with Ferric Carboxymaltose
0 cites
US12285431utility2025
Treatment of Rb-negative Tumors Using Topoisomerase Inhibitors in Combination with Cyclin Dependent Kinase 4/6 Inhibitors
0 cites
US12264135utility2025
Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
0 cites
US12030962utility2024
Stable Iron Oligosaccharide Compound
0 cites
US11851504utility2023
Stable Iron Oligosaccharide Compound
0 cites
US11806329utility2023
Treating Iron Deficiency with Ferric Carboxymaltose
0 cites
US11633489utility2023
Iron Carbohydrate Complex for Treatment of Iron Deficiency of a Fetus or an Infant
0 cites